दवाओं की अंतःक्रिया
Brexucabtagene autoleucel + Natalizumab
गंभीरता: गंभीर
Brexucabtagene autoleucel and Natalizumab: major interaction.
अंतिम अपडेट
केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।
इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।
सारांश
Natalizumab adds to the immunosuppression of CAR T-cell therapy, which already causes prolonged cytopenias and low immunoglobulins. Natalizumab also carries a risk of progressive multifocal leukoencephalopathy that may be heightened by additional immune compromise.
इस इंटरैक्शन का सरल भाषा में अर्थ
Brexucabtagene autoleucel and Natalizumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Brexucabtagene autoleucel belongs to Oncology; Natalizumab belongs to Gastrointestinal Tract.
ऐसा क्यों होता है
Additive immunosuppression from impaired lymphocyte trafficking and CAR T-related immune depletion.
क्या करें
Avoid concurrent use where possible and time natalizumab discontinuation with the treating specialists. Monitor for infection and neurological signs suggesting PML.
फार्मासिस्ट से क्या पूछें
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ सदस्यों के लिए
पूरा पेज खोलें
Brexucabtagene autoleucel और Natalizumab की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
वेब पर Pro+ को 7 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।
Natalizumab के अन्य इंटरैक्शन
Brexucabtagene autoleucel के अन्य इंटरैक्शन
अक्सर पूछे जाने वाले प्रश्न
Can I take Brexucabtagene autoleucel with Natalizumab?
MediHelp rates the interaction as major. Brexucabtagene autoleucel and Natalizumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Natalizumab adds to the immunosuppression of CAR T-cell therapy, which already causes prolonged cytopenias and low immunoglobulins. Natalizumab also carries a risk of progressive multifocal leukoencephalopathy that may be heightened by additional immune compromise.
How serious is the interaction between Brexucabtagene autoleucel and Natalizumab?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use where possible and time natalizumab discontinuation with the treating specialists. Monitor for infection and neurological signs suggesting PML.
What other medicines interact with Natalizumab?
MediHelp also lists interactions of Natalizumab with, for example, Vedolizumab, Axicabtagene ciloleucel, Baricitinib. The full list is on the Natalizumab page.
MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर
MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।
